{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:27:52Z","timestamp":1793914072165,"version":"4.8.0"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Since the emergence of COVID-19 in December 2019, the novel SARS-CoV-2 virus has primarily affected adults, with children representing a smaller proportion of cases. However, the escalation of the pandemic has led to a notable increase in pediatric cases of Multisystem Inflammatory Syndrome in Children (MIS-C). The pathogenesis of MIS-C is largely attributed to immune-mediated mechanisms, such as cytokine storms and endothelial damage, following SARS-CoV-2 infection. In this review, we comprehensively describe MIS-C, including its definitions as proposed by the CDC, WHO, and RCPCH, which emphasize persistent fever, excessive inflammatory responses, and multi-organ involvement. Additionally, we summarize current treatment approaches, prioritizing immunotherapy with intravenous immunoglobulin and corticosteroids, along with anticoagulation therapy, and monoclonal antibodies in severe cases.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1551122","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T05:14:01Z","timestamp":1739942041000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Progress on diagnosis and treatment of multisystem inflammatory syndrome in children"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhe","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6914e4","article-title":"Coronavirus disease 2019 in children - United States, February 12-April 2, 2020","volume":"69","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-020-03766-6","article-title":"Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach","volume":"180","author":"Sperotto","year":"2021","journal-title":"Eur J Pediatr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2020.08.001","article-title":"Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation","volume":"38","author":"Radia","year":"2021","journal-title":"Paediatr Respir Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7104a1","article-title":"Council of state and territorial epidemiologists\/CDC surveillance case definition for multisystem inflammatory syndrome in children associated with SARS-coV-2 infection - United States","volume":"71","author":"Melgar","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.11.145","article-title":"Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis","volume":"102","author":"Zou","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2020.07.004","article-title":"Multisystem inflammatory syndrome in children: Is there a linkage to Kawasaki disease","volume":"30","author":"Loke","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12347","article-title":"The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children","volume":"37","author":"Yang","year":"2021","journal-title":"Kaohsiung J Med Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.201600","article-title":"Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names","volume":"192","author":"Tam","year":"2022","journal-title":"CMAJ"},{"key":"B10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11882-022-01031-4","article-title":"Multisystem inflammatory syndrome in children (MIS-C)","volume":"22","author":"Patel","year":"2022","journal-title":"Curr Allergy Asthma Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"101112","DOI":"10.1016\/j.eclinm.2021.101112","article-title":"Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents","volume":"40","author":"Geva","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19","volume":"325","author":"Feldstein","year":"2021","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.0504","article-title":"Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome","volume":"78","author":"LaRovere","year":"2021","journal-title":"JAMA Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11478","article-title":"Treatment of multisystem inflammatory syndrome in children: understanding differences in results of comparative effectiveness studies","volume":"4","author":"Melgar","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. Children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6932e2","article-title":"COVID-19-associated multisystem inflammatory syndrome in children - United States, March-July 2020","volume":"69","author":"Godfred-Cato","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-063259","article-title":"Updated case definition of MIS-C and implications for clinical care","volume":"153","author":"Day-Lewis","year":"2024","journal-title":"Pediatrics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3390\/children10101661","article-title":"Renal involvement in multisystem inflammatory syndrome in children: not only acute kidney injury","volume":"10","author":"Meneghel","year":"2023","journal-title":"Children (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/apa.v112.3","article-title":"Multisystem inflammatory syndrome in children associated with COVID-19 presenting as cervical inflammation","volume":"112","author":"Brooks","year":"2023","journal-title":"Acta Paediatr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-021-03993-5","article-title":"Multisystem inflammatory syndrome in children related to COVID-19: a systematic review","volume":"180","author":"Hoste","year":"2021","journal-title":"Eur J Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"102151","DOI":"10.1016\/j.epsc.2021.102151","article-title":"Pediatric appendicitis in times of COVID-19: Think MIS-C","volume":"77","author":"Alotaibi","year":"2022","journal-title":"J Pediatr Surg Case Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jpr3.12113","article-title":"Multisystem inflammatory syndrome in children presenting as acute severe necrotizing pancreatitis: A case report","volume":"5","author":"Distel","year":"2024","journal-title":"JPGN Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46100681","article-title":"A study of hydroelectrolytic and acid-base disturbances in MIS-C patients: A perspective on antidiuretic hormone secretion","volume":"46","author":"Petrea Cliveti","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"173455","DOI":"10.1016\/j.ejphar.2020.173455","article-title":"Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting","volume":"884","author":"Sharifkashani","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/0003134820983198","article-title":"Extracorporeal membrane oxygenation for COVID-19-associated multisystem inflammatory syndrome in a 5-year-old","volume":"88","author":"Schwartz","year":"2022","journal-title":"Am Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021756","article-title":"Multisystem inflammatory syndrome in children in new york state","volume":"383","author":"Dufort","year":"2020","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"101032","DOI":"10.1016\/j.jhepr.2024.101032","article-title":"Oxytocin alleviates liver fibrosis via hepatic macrophages","volume":"6","author":"Zhai","year":"2024","journal-title":"JHEP Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2018-0404","article-title":"Decreased S1P and SPHK2 are involved in pancreatic acinar cell injury","volume":"13","author":"Xiao","year":"2019","journal-title":"biomark Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00859","article-title":"Mogroside II(E) inhibits digestive enzymes via suppression of interleukin 9\/interleukin 9 receptor signalling in acute pancreatitis","volume":"11","author":"Xiao","year":"2020","journal-title":"Front Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00018-024-05114-5","article-title":"KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3\/Akt\/mTOR pathway","volume":"81","author":"Zhang","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab285","article-title":"Distinct cytokine and chemokine dysregulation in hospitalized children with acute coronavirus disease 2019 and multisystem inflammatory syndrome with similar levels of nasopharyngeal severe acute respiratory syndrome coronavirus 2 shedding","volume":"224","author":"Peart Akindele","year":"2021","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1088773","article-title":"Neurological manifestations of Kawasaki disease and multisystem inflammatory syndrome in children associated with COVID-19: A comparison of two different clinical entities","volume":"10","author":"Mauro","year":"2022","journal-title":"Front Pediatr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12969-022-00771-x","article-title":"Similarities and differences between MIS-C and KD: a systematic review and meta-analysis","volume":"20","author":"Tong","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The immunology of multisystem inflammatory syndrome in children with COVID-19","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.v183.4","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1016\/j.cell.2023.06.012","article-title":"Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C)","volume":"186","author":"Gruber","year":"2023","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2001010","DOI":"10.2807\/1560-7917.ES.2020.25.22.2001010","article-title":"SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020","volume":"25","author":"Belot","year":"2020","journal-title":"Euro Surveill"},{"key":"B39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","article-title":"Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum","volume":"22","author":"Weisberg","year":"2021","journal-title":"Nat Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-024-00798-y","article-title":"Treatment of multisystem inflammatory syndrome in children","volume":"20","author":"Tong","year":"2024","journal-title":"World J Pediatr"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of covid-19 in new york city","volume":"382","author":"Goyal","year":"2020","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2010722117","article-title":"Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation","volume":"117","author":"Cheng","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae480","article-title":"Rare genetic variants of NLRP12 in admixed latino-american children with SARS-coV-2-related multisystem inflammatory syndrome","volume":"230","author":"Barreto","year":"2024","journal-title":"J Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2021.06.009","article-title":"Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors","volume":"121","author":"Yang","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-coV-2","volume":"324","author":"Whittaker","year":"2020","journal-title":"JAMA"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1042","article-title":"Multi-inflammatory syndrome in children related to severe acute respiratory syndrome coronavirus 2 (SARS-coV-2) in Spain","volume":"72","author":"Moraleda","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.048360","article-title":"Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic","volume":"142","author":"Belhadjer","year":"2020","journal-title":"Circulation."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.056","article-title":"Echocardiographic findings in pediatric multisystem inflammatory syndrome associated with COVID-19 in the United States","volume":"76","author":"Matsubara","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020202288","article-title":"Cardiac MRI in children with multisystem inflammatory syndrome associated with COVID-19","volume":"297","author":"Blondiaux","year":"2020","journal-title":"Radiology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.3390\/jcm11195921","article-title":"A comprehensive review of pediatric acute encephalopathy","volume":"11","author":"Imataka","year":"2022","journal-title":"J Clin Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-022-02907-y","article-title":"Medium-term cardiac outcomes in young people with multi-system inflammatory syndrome: the era of COVID-19","volume":"43","author":"Wong","year":"2022","journal-title":"Pediatr Cardiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0817-4","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","volume":"26","author":"Xu","year":"2020","journal-title":"Nat Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e13900","DOI":"10.1111\/pai.13900","article-title":"Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper","volume":"34","author":"Feleszko","year":"2023","journal-title":"Pediatr Allergy Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1002\/art.42062","article-title":"American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-coV-2 and hyperinflammation in pediatric COVID-19: version 3","volume":"74","author":"Henderson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12519-021-00499-w","article-title":"Clinical practice guidelines in multisystem inflammatory syndrome (MIS-C) related to COVID-19: a critical review and recommendations","volume":"18","author":"Algarni","year":"2022","journal-title":"World J Pediatr"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-061297","article-title":"Early treatment of multisystem inflammatory syndrome in children","volume":"152","author":"Jonat","year":"2023","journal-title":"Pediatrics"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-023-01083-0","article-title":"Multisystemic inflammatory syndrome in children and kawasaki disease: parallels in pathogenesis and treatment","volume":"23","author":"Cannon","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-024554","article-title":"Multisystem inflammatory syndrome in children: an international survey","volume":"147","author":"Bautista-Rodriguez","year":"2021","journal-title":"Pediatrics"},{"key":"B62","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.immuni.2020.11.003","article-title":"The SPPL3-defined glycosphingolipid repertoire orchestrates HLA class I-mediated immune responses","volume":"54","author":"Jongsma","year":"2021","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpeds.2020.10.026","article-title":"Multisystem inflammatory syndrome in children: survey of protocols for early hospital evaluation and management","volume":"229","author":"Dove","year":"2021","journal-title":"J Pediatr"},{"key":"B64","doi-asserted-by":"publisher","first-page":"100431","DOI":"10.1016\/j.xcrm.2021.100431","article-title":"Unraveling the mechanisms of IVIG immunotherapy in MIS-C","volume":"2","author":"Ganigara","year":"2021","journal-title":"Cell Rep Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.01.20241364","article-title":"Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity","volume":"54","author":"Ramaswamy","year":"2021","journal-title":"medRxiv"},{"key":"B66","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","article-title":"The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders","volume":"127","author":"Ballow","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000609","article-title":"New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases","volume":"27","author":"Norris","year":"2020","journal-title":"Curr Opin Hematol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12519-022-00681-8","article-title":"Impact of time to diagnosis on the occurrence of cardiogenic shock in MIS-C post-COVID-19 infection","volume":"19","author":"Bichali","year":"2023","journal-title":"World J Pediatr"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.667507","article-title":"Best practice recommendations for the diagnosis and management of children with pediatric inflammatory multisystem syndrome temporally associated with SARS-coV-2 (PIMS-TS; multisystem inflammatory syndrome in children, MIS-C) in Switzerland","volume":"9","author":"Schlapbach","year":"2021","journal-title":"Front Pediatr"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00223-X","article-title":"Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs","volume":"3","author":"Crosby","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.0292","article-title":"Short-term outcomes of corticosteroid monotherapy in multisystem inflammatory syndrome in children","volume":"176","author":"Villacis-Nunez","year":"2022","journal-title":"JAMA Pediatr"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-008-0210-7","article-title":"Pulse steroid therapy","volume":"75","author":"Sinha","year":"2008","journal-title":"Indian J Pediatr"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0898","article-title":"Genomic and nongenomic effects of glucocorticoids","volume":"4","author":"Stahn","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa2102605","article-title":"Multisystem inflammatory syndrome in children - initial therapy and outcomes","volume":"385","author":"Son","year":"2021","journal-title":"N Engl J Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0694","article-title":"Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children","volume":"325","author":"Ouldali","year":"2021","journal-title":"JAMA"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2020.1292","article-title":"COVID-2019: update on epidemiology, disease spread and management","volume":"90","author":"Sahu","year":"2020","journal-title":"Monaldi Arch Chest Dis"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.753123","article-title":"MIS-C treatment: is IVIG always necessary","volume":"9","author":"Licciardi","year":"2021","journal-title":"Front Pediatr"},{"key":"B79","volume-title":"In Coronavirus Disease 2019 (COVID-19) Treatment Guidelines","year":"2021"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1054-6","article-title":"Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection","volume":"26","author":"Carter","year":"2020","journal-title":"Nat Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.cell.2020.09.034","article-title":"Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C).","volume":"183","author":"Gruber","year":"2020","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147076","article-title":"Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C","volume":"131","author":"Zhu","year":"2021","journal-title":"J Clin Invest"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-021-00419-y","article-title":"Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis","volume":"17","author":"Toraih","year":"2021","journal-title":"World J Pediatr"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.3390\/jcm12062429","article-title":"Identification of clinical response predictors of tocilizumab treatment in patients with severe COVID-19 based on single-center experience","volume":"12","author":"Schmidt","year":"2023","journal-title":"J Clin Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01792-08","article-title":"Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells","volume":"83","author":"Yoshikawa","year":"2009","journal-title":"J Virol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of tocilizumab in patients hospitalized with covid-19","volume":"383","author":"Stone","year":"2020","journal-title":"N Engl J Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2020.1780307","article-title":"Tocilizumab for COVID-19: a real \u2018miracle drug\u2019","volume":"52","author":"Nasim","year":"2020","journal-title":"Infect Dis (Lond)"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0451-z","article-title":"COVID-19 revisiting inflammatory pathways of arthritis","volume":"16","author":"Schett","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/s41467-022-30357-w","article-title":"An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease","volume":"13","author":"Ghosh","year":"2022","journal-title":"Nat Commun"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-021-2340-1","article-title":"Anakinra in refractory multisystem inflammatory syndrome in children (MIS-C)","volume":"58","author":"Bhat","year":"2021","journal-title":"Indian Pediatr"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.942455","article-title":"Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19","volume":"10","author":"Caglayan","year":"2022","journal-title":"Front Pediatr"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/children11101180","article-title":"Clinical effectiveness of biological immunomodulators in SARS-coV-2-associated multisystem inflammatory syndrome in children: A systematic review","volume":"11","author":"Lee","year":"2024","journal-title":"Children (Basel)"},{"key":"B99","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/annrheumdis-2020-217960","article-title":"Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort","volume":"79","author":"Pouletty","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140970","article-title":"Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2","volume":"130","author":"Diorio","year":"2020","journal-title":"J Clin Invest"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1038\/s41598-017-18387-7","article-title":"Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial","volume":"8","author":"Mori","year":"2018","journal-title":"Sci Rep"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-021-03935-1","article-title":"SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment","volume":"180","author":"Abdel-Haq","year":"2021","journal-title":"Eur J Pediatr"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002809","article-title":"Pediatric crohn disease and multisystem inflammatory syndrome in children (MIS-C) and COVID-19 treated with infliximab","volume":"71","author":"Dolinger","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004218","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280603","article-title":"The successful use of eculizumab for treatment of thrombotic microangiopathy in pediatric acute SARSCoV2 infection and multisystem inflammatory syndrome in children","volume":"107","author":"Aurora","year":"2022","journal-title":"Haematologica"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.11.012","article-title":"Coronavirus disease 2019 (COVID-19) in children: Evolving epidemiology, immunology, symptoms, diagnostics, treatment, post-COVID-19 conditions, prevention strategies, and future directions","volume":"6749","author":"Wurm","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11908-022-00779-0","article-title":"COVID-19 infection in children: diagnosis and management","volume":"24","author":"Zhu","year":"2022","journal-title":"Curr Infect Dis Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26224","article-title":"Multisystem inflammatory syndrome in children related to COVID-19: A New York City experience","volume":"93","author":"Riollano-Cruz","year":"2021","journal-title":"J Med Virol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-020-03440-7","article-title":"Multisystem inflammatory syndrome in children in COVID-19 pandemic","volume":"87","author":"Shah","year":"2020","journal-title":"Indian J Pediatr"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of kawasaki disease: A scientific statement for health professionals from the american heart association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(20)30304-7","article-title":"A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process","volume":"5","author":"Harwood","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/febs.v288.17","article-title":"The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID-19 infection","volume":"288","author":"Merzon","year":"2021","journal-title":"FEBS J"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0367-5","article-title":"Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children","volume":"20","author":"Rowley","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.5811\/westjem","article-title":"Multisystem inflammatory syndrome in children","volume":"23","author":"Waseem","year":"2022","journal-title":"West J Emerg Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30651-4","article-title":"COVID-19 and multisystem inflammatory syndrome in children and adolescents","volume":"20","author":"Jiang","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B119","doi-asserted-by":"publisher","first-page":"m2094","DOI":"10.1136\/bmj.m2094","article-title":"Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study","volume":"369","author":"Toubiana","year":"2020","journal-title":"BMJ"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3390\/children9121809","article-title":"Neurological involvement in children with COVID-19 and MIS-C: A retrospective study conducted for more than two years in a pediatric hospital","volume":"9","author":"Abbati","year":"2022","journal-title":"Children (Basel)"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3390\/children11101174","article-title":"Proteomic signatures of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19: A narrative review","volume":"11","author":"Dourdouna","year":"2024","journal-title":"Children (Basel)"},{"key":"B122","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.3390\/jcm13237177","article-title":"Prognostic value of baseline serum pro-inflammatory cytokines in severe multisystem inflammatory syndrome in children","volume":"13","author":"Bartha-Tatar","year":"2024","journal-title":"J Clin Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"156797","DOI":"10.1016\/j.cyto.2024.156797","article-title":"Serum endocan (ESM-1) as diagnostic and prognostic biomarker in Multisystem inflammatory syndrome in children (MIS-C)","volume":"184","author":"Cannavo","year":"2024","journal-title":"Cytokine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1551122\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T05:14:07Z","timestamp":1739942047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1551122\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":123,"alternative-id":["10.3389\/fimmu.2025.1551122"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1551122","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"article-number":"1551122"}}